Final version published [Regulatives / Guidelines]

posted by Panks.79 – 2010-03-08 08:22 (5939 d 09:01 ago) – Posting: # 4875
Views: 26,813

Hi,

This is my first post on this forum, so kindly forgive me for any mistakes.

These guidelines are for IR products. Can this be applicable to MR product also. Can we assume that the CminSS is not required for MR product also.

Also would like to know if by anyways we can justify a steady state study that has failed at steady state for Cmin.

Thanks.

Dr. Pankaj Patil

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
116 visitors (0 registered, 116 guests [including 16 identified bots]).
Forum time: 18:23 CEST (Europe/Vienna)

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5